Koeppen
Carsten Koeppen, Rellingen DE
Patent application number | Description | Published |
---|---|---|
20100252688 | DEVICE AND METHOD FOR CONVERTING SUPPLIED ELECTRICAL POWER INTO MECHANICAL POWER TO START AT LEAST ONE ENGINE - The present invention relates in to a device for supplying mechanical power to start at least one engine, with a power supply device for supplying electrical power with an alternating voltage and constant frequency; and with a number, N1, of conversion devices for the conversion of the supplied electrical power to a respective mechanical power for a respective engine, wherein a respective conversion device has a cascade starter generator for direct conversion of the supplied electrical power to mechanical power, wherein the cascade starter generator has a first stator, a second stator, a first rotor and a second rotor, the first stator being integrally formed with the second stator and the first rotor being integrally formed with the second rotor. The present invention further relates to an aircraft comprising such a power distribution network and a method for supplying mechanical power to start at least one engine in an aircraft. | 10-07-2010 |
20120001481 | POWER DISTRIBUTION DEVICE FOR DISTRIBUTING POWER AND A METHOD FOR THE DISTRIBUTION OF POWER - A power distribution device has a number N | 01-05-2012 |
Christina Koeppen, Muenster DE
Patent application number | Description | Published |
---|---|---|
20150357173 | LASER ABLATION ATMOSPHERIC PRESSURE IONIZATION MASS SPECTROMETRY - In an embodiment, the present invention provides an apparatus for mass spectrometry which includes a laser ablation sampler comprising a laser ablation chamber and a laser. The laser ablation chamber is configured so that the laser can irradiate and ablate a material from a sample to generate an ablated sample material. An atmospheric pressure ionization source generates an ion population. The atmospheric pressure ionization source is operatively connected to the laser ablation chamber via a transfer line so that an ablated sample material is transportable thereto. A mass spectrometer is operatively connected to the laser ablation chamber and to the atmospheric pressure ionization source. The ablated sample material interacts with the atmospheric pressure ionization source to generate an ion population having a mass-to-charge ratio distribution. The ion population is transmitted to the mass spectrometer, which provides information on a mass-to-charge ratio distribution of the ion population. | 12-10-2015 |
Friederike Koeppen, Asperg DE
Patent application number | Description | Published |
---|---|---|
20150093285 | MAGNETIC MATERIAL, USE THEREOF AND METHOD FOR PRODUCING SAME - The present invention relates to a magnetic material, which contains at least one transition metal (TM), at least one rare earth metal (RE) and tungsten, wherein the proportion of transition metal (TM) is 60 to 90% by mass, the proportion of rare earth metal (RE) is 10 to 20% by mass, and the proportion of tungsten (W) is 5 to 25% by mass, in each case in relation to the total mass of the magnetic material. | 04-02-2015 |
Hartmut Koeppen, San Mateo, CA US
Patent application number | Description | Published |
---|---|---|
20130078252 | COMBINATION TREATMENTS COMPRISING C-MET ANTAGONISTS AND B-RAF ANTAGONISTS - The present invention relates generally to the fields of molecular biology and growth factor regulation. More specifically, the invention relates to therapies for the treatment of pathological conditions, such as cancer. | 03-28-2013 |
20130115626 | ANTI-NEUROPILIN ANTIBODIES AND METHODS OF USE - The invention provides anti-NRP1 antibodies and methods of using the same. | 05-09-2013 |
20140038959 | METHODS OF TREATING TUMORS - The present invention relates to a method of treating tumors wherein PAK1 is over-expressed or amplified by co-administering a PAK1 inhibitor and a second anti-hyper-proliferative agent | 02-06-2014 |
20150071910 | BIOMARKERS AND METHODS OF TREATING PD-1 AND PD-L1 RELATED CONDITIONS - Provided herein are biomarkers for the treatment of pathological conditions, such as cancer, and method of using PD-1/PD-L1 pathway antagonists. In particular, provided are biomarkers for patient selection and prognosis in cancer, as well as methods of therapeutic treatment, articles of manufacture and methods for making them, diagnostic kits, methods of detection and methods of advertising related thereto. | 03-12-2015 |
20150125452 | COMBINATION TREATMENTS COMPRISING C-MET ANTAGONISTS AND B-RAF ANTAGONISTS - The present invention relates generally to the fields of molecular biology and growth factor regulation. More specifically, the invention relates to therapies for the treatment of pathological conditions, such as cancer. | 05-07-2015 |